Randomized Conversion of Calcineurin-Inhibitors in Renal Allograft Recipients

NCT00866879 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

275

Enrollment

OTHER

Sponsor class

Conditions

Renal Transplant Rejection

Interventions

DRUG: Sirolimus
OTHER: Demographic Data, Medical History, and Donor Data
PROCEDURE: Blood Draws for Control Group
PROCEDURE: Blood Draws for Experimental Group
PROCEDURE: Donor Blood Draws
OTHER: Donor Information
PROCEDURE: Kidney Biopsy

Sponsor

Northwestern University

Collaborators

[object Object]